Verona Pharma plc buy Roth Capital
Start price
11.01.25
/
50%
€0.51
Target price
11.01.26
-
Performance (%)
-
End price
12.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Roth_Capital for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Roth_Capital gewählte maximale Laufzeit wurde überschritten